Celltrion Snatches First Canadian Xolair Biosimilar Approval
Omlyclo Is Already Approved In The EU, The UK, And South Korea
After a year of multiple regulatory milestones for its Omlyclo, Celltrion celebrates the first omalizumab biosimilar approval in Canada.
